Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06604897

Effectiveness of Entresto (Sacubitril/Valsartan) in Japanese Patients With Hypertension

Effectiveness of Entresto (Sacubitril/Valsartan) to Blood Pressure Control in Japanese Patients With Hypertension: the Database Analysis of Electronic Medical Records

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
1,405 (actual)
Sponsor
Novartis · Industry
Sex
All
Age
18 Years
Healthy volunteers

Summary

This study is a non-interventional, secondary use of data, retrospective, cohort study, and the data to be extracted in this study will be used as secondary use of collected patient information in the database (Japan Medical Data Survey \[JAMDAS\]) owned by M3 Inc. JAMDAS is a database that aggregates medical information and is constructed mainly from electronic medical record information of general practices, allowing real-time extraction of information entered in medical records, such as prescription status including drug switching and continuation, laboratory values, clinical evaluation scores, and comorbidities, etc.

Conditions

Timeline

Start date
2023-01-31
Primary completion
2025-03-31
Completion
2025-03-31
First posted
2024-09-20
Last updated
2024-09-20

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06604897. Inclusion in this directory is not an endorsement.

Effectiveness of Entresto (Sacubitril/Valsartan) in Japanese Patients With Hypertension (NCT06604897) · Clinical Trials Directory